Efficacy and safety of Remicade® (infliximab) plus Arava™ (Leflunomide) in rheumatoid arthritis (RA).

被引:0
作者
Patel, S
Bergen, W
Kraemer, A
Keenan, GF
机构
来源
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
189
引用
收藏
页码:S84 / S84
页数:1
相关论文
共 50 条
  • [21] Infliximab treatment of rheumatoid arthritis (RA).
    Runge, LA
    Pelkey, NL
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 110 - 110
  • [22] Five year follow-up: Efficacy and safety of leflunomide (LEF) in patients with active rheumatoid arthritis (RA).
    Kalden, J
    Schattenkirchner, M
    Sorensen, H
    Emery, P
    Deighton, C
    Rozman, B
    Breedveld, F
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S173 - S173
  • [23] Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trial
    Kalden, J. R.
    Nuesslein, H. G.
    Wollenhaupt, J.
    Burmester, G. -R.
    Krueger, K.
    Antoni, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (05) : 834 - 840
  • [24] The cost utility of adalimumab (HUMIRA®) and infliximab (REMICADE) in the treatment of patients with early rheumatoid arthritis (RA):: US analysis
    Davies, AS
    Hutton, J
    Cifaldi, MA
    Pang, F
    Spencer-Green, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 393 - 393
  • [25] BUDGET IMPACT ANALYSIS OF REIMBURSEMENT OF ARAVA® (LEFLUNOMIDE) IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN POLAND
    Kawalec, P.
    Gierczynski, J.
    Lis, J.
    Glasek, M.
    VALUE IN HEALTH, 2009, 12 (07) : A436 - A436
  • [26] Efficacy and safety of leflunomide in rheumatoid arthritis patients treated in an outpatient clinic
    Müller, T
    Liebscher, B
    Yazdani-Biuki, B
    Eder, S
    Gretler, J
    Brezinschek, H
    Hermann, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 423 - 423
  • [27] Safety evaluation of leflunomide in rheumatoid arthritis
    Keen, Helen I.
    Conaghan, Philip G.
    Tett, Susan E.
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 581 - 588
  • [28] Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis:: Safety and efficacy in an open-label clinical trial
    Antoni, CE
    Nüsslein, HG
    Wollenhaupt, J
    Burmester, GR
    Krüger, K
    Kalden, JR
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 276 - 276
  • [29] OPEN LABEL PROSPECTIVE STUDY OF THE SAFETY AND EFFICACY OF COMBINATION THERAPY WITH LEFLUNOMIDE AND INFLIXIMAB IN PATIENTS WITH RA AND A PARTIAL RESPONSE TO LEFLUNOMIDE
    Bingham, S. J.
    Buch, M. H.
    Conaghan, P. G.
    Lindsay, S.
    Emery, P.
    RHEUMATOLOGY, 2002, 41 : 94 - 95
  • [30] Therapeutic efficacy and safety of methotrexate plus leflunomide in Colombian patients with active rheumatoid arthritis refractory to conventional treatment
    Londono, John
    Maria Santos, Ana
    Ivan Santos, Pedro
    Fernanda Cubidez, Maria
    Guzman, Claudia
    Valle-Onate, Rafael
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2012, 52 (06) : 830 - 845